Evidence map›Paper›PMID 11673474›Full record

ArticleThe Journal of cell biology2001

Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis.

V L Seewaldt, K Mrózek, R Sigle, E C Dietze, K Heine, D M Hockenbery, K B Hobbs, L E Caldwell

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The extracellular matrix as an adhesion checkpoint for mammary epithelial function.The international journal of biochemistry & cell biology · 2007
    Review
  8. Article
  9. Article
  10. Integrins in mammary gland development and differentiation of mammary epithelium.Journal of mammary gland biology and neoplasia · 2003
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

V L SeewaldtDivision of Medical Oncology, Duke University, Durham, NC 27710, USA. seewa0001@mc.duke.edu
K Mrózek
R Sigle
E C Dietze
K Heine
D M Hockenbery
K B Hobbs
L E Caldwell
Fred Hutch Cancer Center · USDuke University · USThe Ohio State University · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI WANCAI YANG · 1985 to 2026
$132.3M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI ANDREW N HOOFNAGLE · 1986 to 2026
$30.4M
Extracellular Matrix Mediated Apoptosis in p53 (-) HMECsR01CA088799 · NCI · DUKE UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2001 to 2010
$2.7M
NCI NIH HHS 2P30CA14236-26NCI NIH HHS 5P30CA16058NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA088799NCI NIH HHS R01CA88799NIDDK NIH HHS 2P30DK 35816-11NIDDK NIH HHS P30 DK035816
6 · The paper itself

Abstract

Little is known about the fate of normal human mammary epithelial cells (HMECs) that lose p53 function in the context of extracellular matrix (ECM)-derived growth and polarity signals. Retrovirally mediated expression of human papillomavirus type 16 (HPV-16) E6 and antisense oligodeoxynucleotides (ODNs) were used to suppress p53 function in HMECs as a model of early breast cancer. p53+ HMEC vector controls grew exponentially in reconstituted ECM (rECM) until day 6 and then underwent growth arrest on day 7. Ultrastructural examination of day 7 vector controls revealed acinus-like structures characteristic of normal mammary epithelium. In contrast, early passage p53- HMEC cells proliferated in rECM until day 6 but then underwent apoptosis on day 7. p53- HMEC-E6 passaged in non-rECM culture rapidly (8-10 passages), lost sensitivity to both rECM-induced growth arrest and polarity, and also developed resistance to rECM-induced apoptosis. Resistance was associated with altered expression of alpha3-integrin. Treatment of early passage p53- HMEC-E6 cells with either alpha3- or beta1-integrin function-blocking antibodies inhibited rECM-mediated growth arrest and induction of apoptosis. Our results indicate that suppression of p53 expression in HMECs by HPV-16 E6 and ODNs may sensitize cells to rECM-induced apoptosis and suggest a role for the alpha3/beta1-heterodimer in mediating apoptosis in HMECs grown in contact with rECM.

Indexed as

ApoptosisAntigens, CDBreastCadherinsCell DivisionCell LineEpithelial CellsExtracellular MatrixGene ExpressionHumansIntegrin alpha3Integrin beta1IntegrinsLamininOligodeoxyribonucleotides, AntisenseOncogene Proteins, ViralAntigens, CDCadherinsE6 protein, Human papillomavirus type 16Integrin alpha3Integrin beta1IntegrinsLamininOligodeoxyribonucleotides, AntisenseOncogene Proteins, ViralRepressor ProteinsTumor Suppressor Protein p53

Identifiers

PMID11673474
PMCPMC2150841
OpenAlexW2003945725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.